CompletedNot Applicable

Interpersonal Psychotherapy-Based Counseling for Hemodialysis Patients: Effect on Adjustment and Depression

Turkey (Türkiye)48 participantsStarted 2025-03-01

Plain-language summary

The aim of this clinical study is to examine the effect of interpersonal psychotherapy-based counseling on adjustment to illness and depression levels in individuals receiving hemodialysis treatment. The main questions this study aims to answer are: Does interpersonal psychotherapy-based counseling improve the adjustment to illness in individuals receiving hemodialysis treatment? Does interpersonal psychotherapy-based counseling reduce depressive symptoms in individuals receiving hemodialysis treatment? The researchers will compare interpersonal psychotherapy-based counseling with routine care to determine its effectiveness in individuals undergoing hemodialysis treatment. Participants: For eight weeks, participants will receive either routine care or interpersonal psychotherapy-based counseling.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • 18 years of age or older, * Hemodialysis treatment for at least 6 months, * Having no problem communicating in Turkish, * No hearing problems and cognitive impairment, * Openness to cooperation, * Not diagnosed with major depression according to DSM-V and ICD-11, * Not having an additional mental disorder, * Not receiving any therapy or treatment, * Receiving hemodialysis treatment at the center 3 days a week, * Do not take care of yourself, * Scoring 10 and above on the Beck Depression Inventory (scores of 10 and above indicate that the participant has depressive symptoms) * Patients who voluntarily agree to participate in the study will be included. Exclusion Criteria: * \- Having a neurological or psychiatric illness that may interfere with reading and understanding the data collection tools, * Have received or are receiving any therapy or treatment, * A score of 10 or less on the Beck Depression Inventory, * Having problems in speaking/understanding Turkish, * Changing cities during research, * Don't want to leave the research, * Receiving a psychiatric diagnosis during research, * Starting therapy or treatment during the research, * Hospitalization during research, * Failure to attend the treatment for 2 consecutive sessions,

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Adaptation to Chronic Diseases Scale

Timeframe: five mounths

Trial details

NCT IDNCT06839287

SponsorBaskent University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-01

View on ClinicalTrials.gov More Hemodialysis trials